With new additions to our Board of Advisors, we are excited to look at the future, which promises to bring with it innovative and cutting-edge data analytics solutions.

A lot has changed for Saama since the beginning of the year. With the announcement of our innovative Clinical Data Management as a Service, we made our popular Fluid Analytics for Life Sciences orchestration stack available as a service. Our customers have also shown great successes, which we’ve published on our web site (with more to come!). And most recently, we added three industry leaders in our Board of Advisors. These industry stalwarts bring with them a deep knowledge and new ways of making a difference in the world around us.

The first one to be announced was Dr. Rebecca Kush, the founder of Clinical Data Interchange Standards Consortium, Inc. (CDISC). Dr. Kush has over 35 years of experience in clinical research and she has held various positions in academia, including the U.S. National Institutes of Health, a global CRO, and biopharmaceutical companies in the U.S. and Japan. She was the President and Chief Executive Officer of the consortium since 1997, its inception year, till April 2017. CDISC has been critical in setting up data standards focused on streamlining clinical research on a global level. These standards now need to be complied with for new submissions to the FDA as well as Japan’s PMDA.